Acro Biosystems Co., Ltd. (301080)
XSHE XSHE Primary Summary
Acro Biosystems Co., Ltd. (301080) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Acro Biosystems Co., Ltd. ever had a stock split?
Acro Biosystems Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Yiding Chen CEO | XSHE Exchange | - ISIN |
| China Country | 869 Employees | - Last Dividend | 11 Jul 2025 Last Split | - IPO Date |
Overview
Acrobiosystems Co., Ltd., founded in 2010 and headquartered in Beijing, China, is a pioneering entity focused on the development and manufacture of critical biological reagents including recombinant proteins and antibodies. Serving the needs of pharmaceutical companies, biotechnology firms, and academic research institutions, the company is dedicated to facilitating the progression of scientific research, drug discovery, and diagnostic development. Acrobiosystems has established a strategic partnership with Diagnostic Biochips Inc, aiming to propel the discovery and commercialization of novel treatments in the field of neurology. This collaboration underscores the company's commitment to innovation and its pivotal role in supporting the advancement of healthcare solutions.
Products and Services
Acrobiosystems offers a comprehensive range of products and services designed to support the various phases of pharmaceutical and academic research. These include:
- Recombinant Proteins: High-quality, bioactive proteins that serve as critical tools in drug discovery and development processes, enabling researchers to study protein interactions, functionality, and structure.
- Antibodies: A diverse catalogue of antibodies meticulously curated for research applications, particularly in the identification, quantification, and study of specific proteins involved in human health and disease.
- Biological Reagents: A broad array of reagents designed to facilitate various biochemical experiments. These products help in simplifying the complexities involved in the research and development activities of pharmaceutical and biotechnological applications.
The collaboration with Diagnostic Biochips Inc further enhances Acrobiosystems' capability to contribute to neurological research, offering targeted solutions that support the discovery and development of new drugs. This partnership highlights the company's continuous endeavor to bridge scientific discoveries to clinical applications, thereby bringing innovative therapeutic solutions closer to reality.
Contact Information
